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RedBook has much more information that is particularly relevant to the pediatrician
orother clinician whoworkswith children.
The Red Book has five major sections, only one of which (Part III) corresponds
directly to what COCDIM tries to do. Of equal or greater importance to the
pediatrician are the other four sections. For example, Part I concerns "Active and
Passive Immunization" (60 pages), which is an excellent primer on the subject and
contains excellent helps, such as recommended immunization schedules (healthy
infants, children not immunized as infants, and the WHO recommendations),
reportable events following immunization, tests and desensitization schedules for
active vaccines and for passive vaccines of human or animal origin, treatment of
anaphylaxis, and immunization ofchildren in special circumstances.
Part II concerns "Recommendations for Care of Children in Special
Circumstances," such as children in day care and in hospitals, internationally
adopted children, sexually transmitted disease in children, and the prevention of
tick-borne infections. Part III contains "Summaries of Infectious Diseases," which
are specifically directed toward pediatric populations.
Part IV is a short (22-page) primer on antimicrobial prophylaxis, with special
emphasis on pediatric surgery, bacterial endocarditis, and neonatal ophthalmia. Part
V concerns the use of "Antimicrobial and Related Therapy" and is about 50 pages
long. Both sections are excellent, with helpful tables, especially an extensive table on
drugs for parasitic infections and the adverse effects ofsuch medications.
Several appendices include a directory oftelephone numbers to call for assistance
with an infection-related problem; a valuable table on what is compensable under
the 1986 National Childhood Vaccine Injury Act; a list of diseases transmitted by
pets, rodents, and other animals; alist ofstate immunization requirements forschool
attendance; and a list ofthe commonly reportable infectious diseases in the U.S.
For clinicians or clinic directors who deal with children, as well as for anyone in
public healthwho is concerned withchildren, theRedBook even ifit is notholywrit,
is a must to have and to use as a text and as a reference.
JAMES F. JEKEL
DepartmentofEpidemiology andPublicHealth
Yale University SchoolofMedicine
HUMAN PHARMACOLOGY: MOLECULAR TO CLINICAL. Edited by Lemuel B. Wingard
Jr., Theodore M. Brody, Joseph Warner, and Arnold Schwartz. St. Louis, MO,
Mosby Year Book, 1991. 926 pp. $47.95.
Trying towrite a perfect textbook for a discipline like pharmacologywhichbridges
both the basic and clinical sciences is like searching for the holy grail; unthwarted
souls may try, but none will ever succeed. HumanPhannacology is an attempt to add
yet another selection to the already unending list ofpharmacology texts.
There already exist texts which cater to every need imaginable: from the encyclo-
pedic Goodman and Gilman'sPhannacologic Basis ofTherapeutics to the mini board
review texts, to a variety of moderately sized ones like Katzung (Basic and Clinical
Pharmacology), Craig and Stitzel (Modem Pharmacology), and Rand and Dale
(Pharmacology). What can Human Pharmacology offer that the others cannot? To
what type ofreaders does the book hope to cater? What special niche can it fill that
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To begin with, Human Pharmacology is a moderately priced book that makes no
pretense tobe as encyclopedic as Goodman and Gilman. Oneofthemain advantages
of the book is its consistency of presentation. Each chapter is presented in five
sections: (1) therapeutic overview; (2) mechanisms of action; (3) pharmacokinetics;
(4) relation ofmechanisms ofaction to clinical response; and (5) side effects, clinical
problems, and toxicity. This arrangement allows the reader to develop a consistent
and organized framework for understanding each major class ofdrugs.
Human Phannacology is particularly good in presenting the mechanisms of action
of each drug class. The generous use of color and diagrams, combined with concise
and simple explanations, adds to the clarity ofthe presentations. This fact alone may
allow the book to stand out, as mechanisms ofaction are, sadly, presented in a bland
and enigmatic manner in most other texts. In addition, the authors make a genuine
effort to relate the mechanism of action to the clinical response of the drug, which
adds invaluably to the student's appreciation ofthe subject matter.
As I forewarned in my caveat to this review, however, all texts have their
shortcomings. Ironically, in Human Phannacology, one of its shortcomings stems
from one of its strengths. In trying to present the mechanisms of action in as clear
and simple a manner aspossible, the authors have risked oversimplifying some ofthe
processes and masked some of the complexities involved that are required for
understanding the toxicity of some of the drugs. Despite the general clarity of the
other sections in each chapter, the pharmacokinetics section often seems to be the
mostconfusing. It is ahodgepodge collection ofdetails, some ofwhich are important,
some of which are not. The section is never divided into absorption, distribution,
metabolism, and excretion, even when appropriate, and seldom divided into drug
subclasses (e.g., antidepressants into tricyclics, second generation, and monoamine
oxidase inhibitors), even ifdoing sowould add greatly to the clarity ofthe section.
In conclusion, I think it isobvious thatHumanPhannacology should notbe used as
a reference text. The clear and colorful presentation ofits subject matter is obtained
at the expense of pharmacokinetic and pharmacodynamic lack of detail. This
presentation may, however, appeal tofirst-time students ofthe subject. I cannot help
but thinkthat thisbookmaynotbe adequate formedical studentswhomight desire a
textbookwith greater depth and substance.
BENHUR LEE
MedicalStudent
Yale University SchoolofMedicine
FRAGILE X/CANCER CYTOGENETICS. Edited by Ann M. Willey and Patricia D.
Murphy. New York, John Wiley & Sons, Inc., 1991. 203 pp. $69.50.
This book is the publication of the 1989 Albany Birth Defects Symposium XX,
held in Albany, New York. Divided into two sections, a long one on fragile X
syndrome and a shorter one on cancer cytogenetics, each chapter represents a talk
given by one of the contributors at the conference. The clinical information pre-
sented in the section on fragile X is interesting and helpful, and provides a useful
compilation ofthe clinical featuresofthe condition. The contribution bySherman on
genetic epidemiology contains helpful information on expression of this condition
within families, on the confusing aspects of transmission within families, and on
prevalence in population studies. There are representative pedigrees demonstrating